Neogen (United States)

Recent papers from Neogen (United States)

1. PS9-26. Estimates of Genetic Parameters for Enteric Gas Fluxes in US Beef Cattle.Journal of Animal Science · 2026
2. Genetic Analysis of Longevity in Brazilian Santa Inês Sheep.Journal of Animal Science · 2026
3. Genotype imputation accuracy of X chromosome variants in Holstein cattle based on different software and imputation strategiesJournal of Dairy Science · 2025
4. Longevity and Culling Reasons in Dairy Herds in Southern BrazilAnimals · 2025
5. Single-cell RNA and TCR repertoire analysis identify markers of virus-specific T cellsImmunobiology · 2025
6. Unicentric Castleman Disease: Updates and Novel Insights Into Spindle Cell Proliferations and Aggressive Forms of a Localized DiseaseInternational Journal of Laboratory Hematology · 2024
7. Effective Classification of Citrus medica L. Var. Sarcodactylis from Different Origins by ICP-MSCurrent Analytical Chemistry · 2024
8. Genome-Wide Association Study of Conformation Traits in Brazilian Holstein CattleAnimals · 2024
9. Statistical considerations when estimating time‐saving treatment effects in Alzheimer's disease clinical trialsAlzheimer s & Dementia · 2024
10. Analytical Determination of Aflatoxin in Ground Corn Check Samples Completed by Multiple Laboratories over Several YearsFoods · 2024
11. An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation.Journal of Clinical Oncology · 2024
12. Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition.Journal of Clinical Oncology · 2024
13. Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples.Journal of Clinical Oncology · 2024
14. Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A*02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition.Journal of Clinical Oncology · 2024
15. Open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-175 in human leukocyte antigen-a*02:01-positive adult subjects with unresectable, advanced and/or metastatic solid tumors that are positive for the TP53 R175H mutation.Journal of Clinical Oncology · 2024
16. A study of the gaps and opportunities with fusion detection beyond NTRKs on 422 patients from the community.Journal of Clinical Oncology · 2024
17. Molecular residual disease (MRD) interception in locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC): MERIDIAN study.Journal of Clinical Oncology · 2024
18. A systematic review with meta‐analysis of heritability estimates for temperament‐related traits in beef and dairy cattle populationsJournal of Animal Breeding and Genetics · 2024
19. Novel non‐linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methodsStatistics in Medicine · 2024
20. Abstract PO2-14-03: Novel Metrics of HER2 Heterogeneity in HER2-Positive and HER2-Low Breast Cancer via High Dimensional Multiplexed Immunofluorescence Spatial ProfilingCancer Research · 2024